IO9 Trademark

Trademark Overview


On Tuesday, November 15, 2022, a trademark application was filed for IO9 with the United States Patent and Trademark Office. The USPTO has given the IO9 trademark a serial number of 97677741. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, December 2, 2024. This trademark is owned by io9, LLC. The IO9 trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Downloadable computer software for detecting and treating cancer using artificial intelligence (AI)

Biological and chemical preparations for the prevention and treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors; Medical reagents; Diagnostic kits comprised of medical diagnostic reagents, assays for testing of bodily fluids for use in disease detection, namely, cancer; stem cells, protein arrays, and molecular compounds for medical purposes; Pharmaceutical preparations for use in oncology; Antitumor drugs in the nature of pharmaceutical preparations

Medical services for the treatment and detection of cancer; Medical analysis services using artificial intelligence (AI) for the diagnosis of cancer; Providing cancer screening services; Providing a website via a global computer network featuring information in the fields of health, cancer, cancer treatment, recovery and survival, and artificial intelligence use in medicine; RNA or DNA analysis for cancer diagnosis and prognosis

Software as a service (saas) services featuring software for detecting and treating cancer using artificial intelligence (AI); Development of pharmaceutical preparations and medicines; Drug discovery services; Medical research in the field of cancer; Pharmaceutical research and development services; Research and development of pharmaceuticals for the treatment of cancer; medical and scientific research, namely, conducting clinical trials for others; DNA screening and analysis services for scientific research purposes
io9

General Information


Serial Number97677741
Word MarkIO9
Filing DateTuesday, November 15, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, December 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements


Description of MarkThe mark consists of the lower case letter "i", "o" and the number 9, in stylized format.
Goods and ServicesDownloadable computer software for detecting and treating cancer using artificial intelligence (AI)
Goods and ServicesBiological and chemical preparations for the prevention and treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors; Medical reagents; Diagnostic kits comprised of medical diagnostic reagents, assays for testing of bodily fluids for use in disease detection, namely, cancer; stem cells, protein arrays, and molecular compounds for medical purposes; Pharmaceutical preparations for use in oncology; Antitumor drugs in the nature of pharmaceutical preparations
Pseudo MarkIO NINE
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical services for the treatment and detection of cancer; Medical analysis services using artificial intelligence (AI) for the diagnosis of cancer; Providing cancer screening services; Providing a website via a global computer network featuring information in the fields of health, cancer, cancer treatment, recovery and survival, and artificial intelligence use in medicine; RNA or DNA analysis for cancer diagnosis and prognosis
Goods and ServicesSoftware as a service (saas) services featuring software for detecting and treating cancer using artificial intelligence (AI); Development of pharmaceutical preparations and medicines; Drug discovery services; Medical research in the field of cancer; Pharmaceutical research and development services; Research and development of pharmaceuticals for the treatment of cancer; medical and scientific research, namely, conducting clinical trials for others; DNA screening and analysis services for scientific research purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateTuesday, December 6, 2022
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 6, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party Nameio9, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLa Jolla, CA 92037

Party Nameio9, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLa Jolla, CA 92037

Trademark Events


Event DateEvent Description
Thursday, September 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 18, 2022NEW APPLICATION ENTERED
Tuesday, December 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 29, 2023ASSIGNED TO EXAMINER
Thursday, September 7, 2023NON-FINAL ACTION WRITTEN
Thursday, September 7, 2023NON-FINAL ACTION E-MAILED
Tuesday, September 12, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 12, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, September 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 12, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, September 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 11, 2024SOU EXTENSION 1 FILED
Tuesday, June 11, 2024SOU EXTENSION 1 GRANTED
Monday, December 2, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 2, 2024SOU EXTENSION 2 FILED
Monday, December 2, 2024SOU EXTENSION 2 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED